BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Thursday, March 12, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
May 9, 2000
View Archived Issues
BioChem Pharma makes solid progress during first quarter
Read More
Cel-Sci's herpes vaccine protective against HSV-1 in preclinical studies
Read More
Preliminary phase II results for Optin in AMD
Read More
IRB approves phase II pancreatic cancer trials of SafeScience's GBC-590
Read More
Idec updates Q1 developments, decides not to pursue SLE indication for IDEC-131
Read More
ImmunoGen product development for Q3 2000
Read More
Novel class of antiviral agents with improved properties
Read More
Patent issued to Isis covers antisense modulation of cREL expression
Read More
M. catarrhalis protein, its isolation and use in vaccines reported by Antex
Read More
Known antianginal agent claimed for use in retinal diseases by French researchers
Read More
Diagnostic imaging of NK1 receptors using Merck compounds
Read More
Preparation and use of new triterpenes as immunosuppressants described by Merck & Co.
Read More
New dopaminergic agents from Neurogen for neuropsychological disorders
Read More
Ares-Serono exercises license option to antiamyloid technology
Read More
Akorn obtains rights to AMD technology
Read More
Schering-Plough drops advanced-stage antibiotic upon final analysis of clinical data
Read More
Pyrimidine nucleosides with potent anti-VZV or anti-EBV activity discussed at recent conference
Read More
Genta's antisense drug active in advanced NHL
Read More
Avant Immunotherapeutics reports second-year rotavirus vaccine results
Read More
Novirio's new anti-HBV nucleosides among Antiviral Research conference highlights
Read More
Draximage files IND for Amiscan in U.S. and Canada
Read More
Study evaluates resveratrol effects in sputum from patients with COPD
Read More
European Commission gives go-ahead for Glaxo Wellcome-SmithKline Beecham merger
Read More
Viozan in the spotlight at ATS meeting
Read More
A promising development candidate for RSV disease: ViroPharma's VP-14637
Read More
GR-215864X: a safer glucocorticoid for asthma undergoes rapid inactivation in plasma
Read More
New Abbott compound at least as effective as ciclosporin, prednisolone in acute primate asthma model
Read More
New Viozan derivatives also enter clinical development for COPD at AstraZeneca
Read More
